Supplementary Figure 1 from Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T
Year: 2023
Type: supplementary-materials
Abstract: Study Schema. The top panel is the study schema for P101 study (treated patients) and the bottom panel is for the STRIDE study schema (naïve patients). As shown in the figure, the treated patients had received sipuleucel-T treatment on average of 8.9 years ago before joined P10-1 study. For both studies, the patients had 3 infusions every 2 weeks (week 0, week 2 and week 4). The baseline was indicated as in the figure, which was right before the 1st infusion. The blood samples were collected at week 0, week 2 and week 4 right before each infusion, as well as at week 6, week 26 and week 52. Both studies have long term follow-up after one year.
Authors: Li Zhang, Harini Kandadi, Hai Yang, Jason Cham, Tao He, David Y. Oh, Nadeem A. Sheikh, Lawrence Fong
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362532584